✦ LIBER ✦

The basel study on the elderly's search for preclinical cognitive markers of Alzheimer's disease

✍ Scribed by Andreas Urs Monsch; Beat Thalmann; Marianne Schneitter; Florence Bernasconi; Chantal Aebi; Zdenka Camachova-Davet; Hannes B. Staehelin

Book ID: 117411964
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 171 KB
Volume: 21
Category: Article
ISSN: 0197-4580
DOI: 10.1016/s0197-4580(00)82817-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cognition and beta-amyloid in preclinica

Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study

✍ Kerryn E. Pike; Kathryn A. Ellis; Victor L. Villemagne; Norm Good; Gael Chételat 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 392 KB

Testing the new diagnostic criteria for

Testing the new diagnostic criteria for Preclinical Alzheimer's Disease: MRI biomarker of Alzheimer's disease-related atrophy in cognitively normal individuals predicts cognitive decline

✍ Brad Dickerson; David Wolk 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Testing the new diagnostic criteria for

Testing the new diagnostic criteria for Preclinical Alzheimer’s disease: MRI biomarker of Alzheimer’s disease-related atrophy in cognitively normal individuals predicts cognitive decline

✍ Brad Dickerson; David Wolk 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Minimal effects of preclinical Alzheimer

Minimal effects of preclinical Alzheimer's disease on cross-sectional age-related cognitive deficits: Evidence from the Kungsholmen study

✍ Erika Jonsson; Oke Wahlin 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Toward defining the preclinical stages o

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

✍ Reisa A. Sperling; Paul S. Aisen; Laurel A. Beckett; David A. Bennett; Suzanne C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 686 KB

A change point model for estimating the

A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease

✍ Charles B. Hall; Richard B. Lipton; Martin Sliwinski; Walter F. Stewart 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

Dementia is characterized by accelerated cognitive decline before and after diagnosis as compared to normal ageing. Determining the time at which that rate of decline begins to accelerate in persons who will develop dementia is important both in describing the natural history of the disease process